Inventor · Westborough, MA, US

Zehra Kaymakcalan

34Patents
21h-index
54Co-inventors
88Inventor score

Filing activity: May 14, 1991 → Jan 28, 2016

Most-cited inventions

PatentTitleAreaCited byStatus
US6090382A Human antibodies that bind human TNF.alpha. Emerging Cross-Sectional Technologies 444 Expired
US6258562A Human antibodies that bind human TNF.alpha. Emerging Cross-Sectional Technologies 307 Expired
US6914128B1 Human antibodies that bind human IL-12 and methods for producing Chemistry; Metallurgy 292 Expired
US6509015B1 Human antibodies that bind human TNFa Emerging Cross-Sectional Technologies 211 Expired
US7223394B2 Human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 160 Expired
US7541031B2 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 147 Active
US7588761B2 Human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 143 Expired
US8414894B2 Human antibodies that bind human TNFα and methods of using same Emerging Cross-Sectional Technologies 73 Active
US8206714B2 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa Emerging Cross-Sectional Technologies 72 Active
US8197813B2 Human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 71 Active
US8372401B2 Human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 70 Active
US8372400B2 Methods of treating disorders using human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 69 Active
US7883704B2 Methods for inhibiting the activity of the P40 subunit of human IL-12 Chemistry; Metallurgy 62 Active
US7504485B2 Human antibodies that bind human IL-12 Chemistry; Metallurgy 62 Expired
US5166133A Method for inhibing adhesion of white blood cells to endothelial cells Chemistry; Metallurgy 58 Expired
US5340800A Peptide medicaments for the treatment of disease Human Necessities 49 Expired
US8753633B2 Human antibodies that bind human TNFα Emerging Cross-Sectional Technologies 49 Active
US7491516B2 Dual specificity antibodies and methods of making and using Chemistry; Metallurgy 46 Expired
US8921526B2 Mutated anti-TNFα antibodies and methods of their use Chemistry; Metallurgy 34 Active
US9085618B2 Low acidic species compositions and methods for producing and using the same Chemistry; Metallurgy 32 Active
US9266949B2 Low acidic species compositions and methods for producing and using the same Chemistry; Metallurgy 24 Active
US9200070B2 Low acidic species compositions and methods for producing and using the same Chemistry; Metallurgy 20 Active
US9181337B2 Modulated lysine variant species compositions and methods for producing and using the same Chemistry; Metallurgy 19 Active
US9200069B2 Low acidic species compositions and methods for producing and using the same Chemistry; Metallurgy 17 Active
US8969024B2 Compositions and methods comprising binding proteins for adalimumab Emerging Cross-Sectional Technologies 16 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.